12:00 AM
 | 
Mar 25, 2013
 |  BC Week In Review  |  Company News  |  Other News

Affymax hematology news

Affymax said it will reduce headcount by about 230 (75%) and retain a bank to evaluate strategic alternatives, including a sale of the company or its assets, further restructuring, winding down operations or bankruptcy proceedings. The headcount reductions...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >